Blocking the interaction between VEGFR-3 on lymphatic vessels and VEGF-C produced by tumors can be a form of tumor suppression through prevention of tumor lymphangiogenesis, which contributes to metastasis and tumor growth (Su et al., 2007). This evidence concerns the gene FLT4 and neoplasm.